Multiple Myeloma Research Foundation (MMRF) Announces Janssen Research & Development Joins Innovative Pre-competitive Consortium to Advance Personalized Medicine Approaches for Multiple Myeloma

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced that Janssen Research & Development, LLC (Janssen R&D) has joined the MMRF pre-competitive consortium (PCC) to discover and accelerate new approaches to treating multiple myeloma through the organization’s Personalized Medicine Initiative (PMI).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC